JLJelena Lilić

Jelena Lilić

*This is an algorithmically generated author record based on publicly available information.

Jelena Lilić has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    PEDIATRIC INJURIES RELATED TO CHILD MALTREATMENT

    by Maja Zečević, Dragoljub Živanović, Ana Bosak-Veršić, Patricia Jakljević, Tamara Adamović, Dragana Lazarević, Vesna Marjanović, Jelena Lilić

    Violence against children is a complex socio-medical phenomenon with potential lifetime consequences. Therefore, it is very important to recognize the first signs of violence, as medical staff are quite often the only witnesses of child maltreatment. The objective was to determine types of abuse and neglect in the pediatric population, which children are most susceptible to abuse and neglect, the kinds and severity of injuries, and the required management. A retrospective study was conducted on all patients admitted to two different hospitals due to suspicion of abuse and neglect, with the involvement of a social worker, over a 6-year period. This study included 473 patients; their average age was 8.03 ± 6.01 years; the majority of children were aged 0 to 3 years (35.0%), and 67.2% were boys. Of them, 82.4% were hospitalized because of injuries and other medical conditions caused by neglect. A total of 17.6% were hospitalized due to suspected abuse: peer violence was present in 59.3% of the cases, 22.1% of the children were abused by their parents, and the least number of patients were abused by unknown persons, 18.6%. Minor injuries were present in 55.39% of the cases. In total, 232 children underwent surgical treatment due to injuries from abuse or neglect. The majority of children were neglected, not abused, and among the abused children peer violence was predominant. The most susceptibile to neglect and abuse were the youngest members of the pediatric population.

  • Open Access

    POPULATION PHARMACOKINETICS OF PANTOPRAZOLE IN PATIENTS ON DUAL ANTIPLATELET THERAPY FOLLOWING ACUTE CORONARY SYNDROME

    by Valentina N. Nikolić, Dragana Stokanović, Slobodan M. Janković, Sandra S. Konstatinović, Jelena B. Zvezdanović, Jelena Lilić, Nikola Stefanović, Svetlana Apostolović, Jasmina R. Milovanović

    This study investigates factors influencing pantoprazole pharmacokinetics (PK) in patients with acute coronary syndrome (ACS) undergoing dual antiplatelet therapy (DAPT) comprising acetylsalicylic acid and clopidogrel, alongside concomitant pantoprazole to mitigate gastrointestinal risks. We conducted a prospective analysis on 93 ACS patients, assessing pantoprazole PK parameters and their correlation with C-reactive protein (CRP) levels, indicative of inflammation. Blood samples for pantoprazole concentration and CRP levels were collected according to a predefined schedule, post-oral pantoprazole administration at steady state. The study highlights a notable influence of CRP levels on pantoprazole clearance, underscoring inflammation’s impact on drug metabolism. Elevated CRP was associated with altered pantoprazole pharmacokinetics, suggesting that inflammatory status significantly contributes to metabolic variability in this patient population. Our findings suggest the need for personalized pantoprazole dosing in ACS patients on DAPT, considering the inflammatory status as reflected by CRP levels. This approach could optimize therapeutic efficacy and minimize adverse effects, advancing personalized treatment strategies in the management of ACS.

  • Open Access

    The Impact of Opioid Receptor Gene Polymorphism on Fentanyl and Alfentanil’s Analgesic Effects in the Pediatric Perioperative Period

    by Jelena Lilic, Vesna G Marjanovic, Ivana Budic, Nikola Stefanovic, Dragana Stokanovic, Goran T Marjanovic, Tatjana Jevtovic-Stoimenov, Mladjan Golubovic, Maja Zecevic, Radmila Velickovic-Radovanovic

    Introduction: The polymorphism of the gene coding mu-opioid receptor (OPRM1) is one of the factors contributing to the variability in the response to opioid analgesics in children. The goal of this study is to investigate its role in association with postoperative acute pain in children of various ages. Methods: This prospective study analyzed 110 pediatric patients, after plastic or orthopedic surgery, who were genotyped and randomly assigned to receive fentanyl or alfentanil. Postoperative pain was rated using Numerical Rating Scale (0– 10). All the patients were genotyped forOPRM1 118A>G (rs1799971) gene polymorphism. Results: School children under the age of 11 with the OPRM1 AA genotype were shown to have a higher BMI (p< 0.05). Children over the age of 12 carrying G allele OPRM1, had increased postoperative pain sensitivity and intensity (3.28± 1.95 vs 4.91± 2.17; p< 0.05), as compared to AA allele carriers. Discussion: OPRM1 118A>G polymorphism may explain the variation in the perception of postoperative pain in children over the age of 12 and may be a useful predictor for adjusting the dose of analgesics, but the dose is relative to the patient’s needs regardless of his genetic characteristics. In younger children, carriers of polymorphic OPRM1 118G allele may be protected from obesity, due to diminished MOP expression.